| Application no. and date | 13785373.5 (espacenet) (Federated) (European Patent Register), 20131011 | | Patent/reg. no. and date | DK/EP 2906296, 20180321 | | Publication date | 20150819 | | Priority no. and date | US 201261712928 P, 20121012, US 201261712924 P, 20121012, US 201361798037 P, 20130315, US 201361798072 P, 20130315, US 201361798106 P, 20130315 | | EP pub. no. and date |
EP 2906296 20150819 | | Effective date | | | Applicant/owner | Medimmune Limited, Milstein Building Granta Park
Cambridge, Cambridgeshire CB21 6GH, GB,
ADC Therapeutics SA, route de la Corniche 3B
1066 Epalinges, CH | | Applicant ref. no. | P81801431DK00E | | Inventor | HOWARD, Philip Wilson, Spirogen Limited
The QMB Innovation Centre
42 New Road
London
Greater London E1 2AX, GB,
VAN BERKEL, Patricius Hendrikus Cornelis, ADC Therapeutics SÃ rl
c/o Michael Forer
Rue Saint-Pierre 2
1003 Lausanne, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/5517 (2006.01) , A61K 45/06 (2006.01) , A61K 47/50 (2017.01) , A61P 35/00 (2006.01) , A61P 39/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Pyrrolobenzodiazepin-antistof-konjugater | | Int. application no. | EP2013071349 | | Int. publication no. | WO2014057119 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
